# Safety and Tolerability Study of ARC-520 in Healthy Volunteers

> **NCT01872065** · PHASE1 · COMPLETED · sponsor: **Arrowhead Pharmaceuticals** · enrollment: 54 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ARC-520
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01872065
- **Lead sponsor:** Arrowhead Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2014-09
- **Final completion:** 2014-11
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2025-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01872065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01872065, "Safety and Tolerability Study of ARC-520 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01872065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*